# Leawood Venture Capital

> Leawood Venture Capital is a VC fund backing Software. See 27 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Leawood, United States
- Total investments: 27
- Last investment: Nov 2025
- Lead investor: 26%
- Last fund: Jan 2019
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/leawood-venture-capital/
- Website: http://www.leawoodvc.com

Leawood Venture Capital is a VC fund in Leawood focused on Software and Artificial Intelligence. Leawood Venture Capital invests in areas where our team has extensive market and technology expertise and can add real value. With deep roots on both coasts, our team has developed strong relationships across the country and can access the best deals from the national centers of technology excellence. Founded by successful founders andexperienced business operators, Leawood Venture Capital has raised multiple funds and invested in more than 25 portfolio companies since 2016.

## Contacts

5 contacts available for Leawood Venture Capital. Shizune tracks 4 team members at Leawood Venture Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/leawood-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 8 | 30% |
| Artificial Intelligence | 7 | 26% |
| Machine Learning | 6 | 22% |
| Information Technology | 5 | 19% |
| Analytics | 4 | 15% |

48 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 10 | 37% |
| Funding Round | 6 | 22% |
| Series B | 5 | 19% |
| Seed | 2 | 7% |
| Convertible Note | 2 | 7% |

7 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Karl Gemperli | Co-Founder, ​Managing Director, and General Partner | 5 | https://shizune.co/investors/profile/karl-gemperli |
| Todd Daniels | Managing Director and ​General Partner | 0 | https://shizune.co/investors/profile/todd-daniels |
| William Fallis | Founder/General Partner/Investment Committee Member | 2 | https://shizune.co/investors/profile/brendan-fallis-3 |
| Patrick Spaulding Ryan | General Partner and Investment Committee | 39 | https://shizune.co/investors/profile/patrick-spaulding-ryan-phd |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Sorcero | Sorcero provides an AI-powered intelligence platform tailored for life sciences teams. It enables medical affairs, safety, scientific communications, and medtech groups to extract meaningful insights from unstructured and structured biomedical data. Through its Instant Insights Engine and agentic AI framework, users can ask conversational questionsand quickly receive medically validated answers linked to their source material. Sorcero also offers tools for literature monitoring, safety signal detection, and converting complex science into clear, plain-language summaries. The platform supports compliant workflows by providing auditability, AI guardrails, and access controls to manage insights securely. | $42.5M | Series B | Nov 21, 2025 |  |
| Gastrograph | Analytical Flavor Systems’ AI-driven Gastrograph platform helps packaged food companies achieve greater success in a saturated food industry that has an over 80% failure rate. Gastograph moves CPG brands’ development process beyond traditional tasting panels; it surveys each product with a flavor profile engine that is predictive, anticipating hownew foods will perform in different markets, over a long time horizon, and against various demographic archetypes. Food companies are struggling to launch new products in an era of rapidly shifting consumer tastes, and an AI-driven platform like Gastrograph gives big food a more accurate map with which to navigate into the future. | $7M | Venture - Series Unknown | Jan 20, 2023 |  |
| Biotia | Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid and precise infectious disease discovery. Their software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes. | $8M | Series A | Aug 23, 2022 |  |
| Quadric | Quadric develops semiconductor intellectual property and tools for on-device artificial intelligence computing. The company creates the Chimera general-purpose neural processing unit family that supports machine learning inference and traditional data processing in a unified architecture. It provides a software development kit and design resourcesthat help chip designers integrate AI capabilities into custom silicon. Quadric engages with developers and hardware teams to support diverse AI workloads across edge devices, automotive systems, and industrial applications. | $21M | Series B | Mar 16, 2022 |  |
| Adlumin | Adlumin empowers modern organizations with advanced technology and top talent for cybersecurity and efficient IT operations. Adlumin was founded with the mission of addressing this challenge through the provision of a platform that proactively identifies the most recent vulnerabilities being exploited and swiftly responds to them in real-time.With the backing of an exceptional team of experts, Adlumin serves as a dedicated partner throughout the entire process, guiding users every step of the way. | $25M | Series B | Dec 07, 2021 |  |
| Sorcero | Sorcero provides an AI-powered intelligence platform tailored for life sciences teams. It enables medical affairs, safety, scientific communications, and medtech groups to extract meaningful insights from unstructured and structured biomedical data. Through its Instant Insights Engine and agentic AI framework, users can ask conversational questionsand quickly receive medically validated answers linked to their source material. Sorcero also offers tools for literature monitoring, safety signal detection, and converting complex science into clear, plain-language summaries. The platform supports compliant workflows by providing auditability, AI guardrails, and access controls to manage insights securely. | $10M | Series A | Sep 16, 2021 |  |
| Sorcero | Sorcero provides an AI-powered intelligence platform tailored for life sciences teams. It enables medical affairs, safety, scientific communications, and medtech groups to extract meaningful insights from unstructured and structured biomedical data. Through its Instant Insights Engine and agentic AI framework, users can ask conversational questionsand quickly receive medically validated answers linked to their source material. Sorcero also offers tools for literature monitoring, safety signal detection, and converting complex science into clear, plain-language summaries. The platform supports compliant workflows by providing auditability, AI guardrails, and access controls to manage insights securely. |  |  | Jul 12, 2021 |  |
| Adlumin | Adlumin empowers modern organizations with advanced technology and top talent for cybersecurity and efficient IT operations. Adlumin was founded with the mission of addressing this challenge through the provision of a platform that proactively identifies the most recent vulnerabilities being exploited and swiftly responds to them in real-time.With the backing of an exceptional team of experts, Adlumin serves as a dedicated partner throughout the entire process, guiding users every step of the way. | $6M | Series A | Sep 28, 2020 |  |
| Sorcero | Sorcero provides an AI-powered intelligence platform tailored for life sciences teams. It enables medical affairs, safety, scientific communications, and medtech groups to extract meaningful insights from unstructured and structured biomedical data. Through its Instant Insights Engine and agentic AI framework, users can ask conversational questionsand quickly receive medically validated answers linked to their source material. Sorcero also offers tools for literature monitoring, safety signal detection, and converting complex science into clear, plain-language summaries. The platform supports compliant workflows by providing auditability, AI guardrails, and access controls to manage insights securely. | $3.5M | Convertible Note | Aug 07, 2020 |  |
| HyperQube | HyperQube is a “cyber range as a service” offering that enables enterprises to quickly and easily build an exact copy of any IT infrastructure. Their virtualized test environments can be built in minutes and just as easily modified, re-used and shared. With the ability to look to the future and explore infrastructures in a risk-free environment,engineers will save hours on labor, security officers will feel assured and executives will conserve thousands of dollars. |  | Seed | Aug 06, 2020 |  |

10 of 27 investments shown.

## Co-investors
- [WorldQuant Ventures LLC](https://shizune.co/investors/profile/worldquant-ventures) — VC Fund, 5 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 3 deals together
- [CityRock Venture Partners](https://shizune.co/investors/profile/cityrock-venture-partners) — VC Fund, 3 deals together
- [Hatzimemos / Libby](https://shizune.co/investors/profile/hatzimemos-libby) — VC Fund, 3 deals together
- [Intel Capital](https://shizune.co/investors/profile/intel-capital) — VC Fund, 3 deals together
- [KCRise Fund](https://shizune.co/investors/profile/kcrise-fund) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Leawood Venture Capital invest in?

Leawood Venture Capital invests primarily in Software, Artificial Intelligence and Machine Learning startups, most often at Series A and Funding Round stage. Most of the 27 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Leawood Venture Capital?

Public channels for Leawood Venture Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Leawood Venture Capital?

The team at Leawood Venture Capital includes Karl Gemperli (Co-Founder, ​Managing Director, and General Partner), Todd Daniels (Managing Director and ​General Partner) and William Fallis (Founder/General Partner/Investment Committee Member). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co